CEO: | Craig Jonathan Gulliford |
CFO: | Richard John Rees |
Chief Technology Officer: | Christopher Paul Hancock |
Executive Director: | David Gerard Woods |
Independent Non-Executive Director: | John Bradshaw |
Independent Non-Executive Director: | Ivonne Cantu |
Non-Executive Chairman: | Charles Spicer |
Non-Executive Dir: |
Address: | Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH |
Phone: | +44 (0) 1291 606005 |
Website: | http://creomedical.com/ |
Sector: | Health Care(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BZ1BLL44 |
Currency | UK Pounds |
Share Price | 34.25p |
Change Today | -0.50p |
% Change | -1.44 % |
52 Week High | 48.10 |
52 Week Low | 23.25 |
Volume | 709,100 |
Shares Issued | 361.48m |
Market Cap | £123.81m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
17:08 | 36,389 @ 34.25p |
16:30 | 15,000 @ 34.38p |
16:29 | 580 @ 34.45p |
16:10 | 29,500 @ 34.50p |
16:03 | 236,617 @ 33.51p |
CEO | Craig Jonathan Gulliford |
CFO | Richard John Rees |
You are here: research